Torii Pharmaceutical Co., Ltd.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a TRXPF research report →
About the company
Torii Pharmaceutical Co. , Ltd. , a Tokyo-based Japanese firm established in 1872, specializes in the development and commercialization of a variety of pharmaceutical products.
- CEO
- Goichi Matsuda
- IPO
- 2013
- Employees
- 583
- HQ
- Tokyo, JP
Price Chart
- Market Cap
- $690.70M
- P/E
- 68.97
- P/S
- 5.69
- P/B
- 1.46
- EV/EBITDA
- 48.44
- Div Yield
- 0.94%
- Gross Margin
- 43.87%
- Op Margin
- 10.04%
- Net Margin
- 8.25%
- ROE
- 2.12%
- ROIC
- 1.91%
- Revenue
- $60.42B · 10.59%
- Net Income
- $5.04B · 22.41%
- EPS
- $179.46 · 22.44%
- Op Income
- $6.80B
- FCF YoY
- 203.59%
- 52W High
- $24.57
- 52W Low
- $24.57
- Beta
- 0.33
- Avg Volume
- 0
Get TickerSpark's AI analysis on TRXPF
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Our TRXPF coverage
Recent articles, reports, and earnings notes.
No research on TRXPF yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate TRXPF report →Similar companies
Peers in the same neighborhood.